Report of a patient with inclusion body myositis and CD8+ chronic lymphocytic leukaemia – post‐mortem analysis
of muscle and brain

We report a 73‐year‐old woman with sporadic inclusion body myositis (s‐IBM) and a T‐cell chronic lymphocytic leukaemia (T‐CLL). The s‐IBM diagnosis was based on clinical symptoms and muscle biopsy showing inflammatory infiltrates and rimmed vacuoles with 15–18 nm diameter tubulofilamentous inclusions on ultrastructural examination. The inflammatory infiltrates consisted of CD8+ T‐lymphocytes and macrophages. The diagnosis of a CD8+ T‐CLL was based on peripheral blood samples and bone marrow aspiration. The post‐mortem analysis of skeletal muscle showed fascicular atrophy, which may support a neurogenic component in s‐IBM and the analysis of the brain showed only a few diffuse plaques in different cortical regions and occasionally neuritic plaques. A pathophysiological analogy between s‐IBM and Alzheimer's has been suggested on the basis of similarities in protein accumulation in muscle of s‐IBM patients and brain of Alzheimer's patients. However, we were unable to detect any changes suggestive of Alzheimer's disease in the brain of the s‐IBM patient presented here.

[1]  H. Gogas,et al.  T-cell lymphoma in Hashimoto's thyroiditis. , 1996, Histopathology.

[2]  M. Dalakas,et al.  Immune‐mediated conditions and antibodies associated with sporadic inclusion body myositis , 1998, Muscle & nerve.

[3]  J. Schröder,et al.  Mitochondrial abnormalities and peripheral neuropathy in inflammatory myopathy, especially inclusion body myositis. , 1997 .

[4]  A. Hedström,et al.  Inclusion body myositis and welander distal myopathy: a clinical, neurophysiological and morphological comparison , 1991, Journal of the Neurological Sciences.

[5]  J Miller,et al.  Inclusion body myositis in HIV-1 and HTLV-1 infected patients. , 1996, Brain : a journal of neurology.

[6]  W. Engel,et al.  Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging. , 1998, Scandinavian journal of rheumatology.

[7]  C. Krarup,et al.  Multiple autoimmune manifestations in monoclonal gammopathy of undetermined significance and chronic lymphocytic leukemia. , 1996, Leukemia.

[8]  W. Engel,et al.  New advances in the understanding of sporadic inclusion‐body myositis and hereditary inclusion‐body myopathies , 1995, Current opinion in rheumatology.

[9]  M. Dalakas,et al.  Inclusion body myositis and myopathies , 1997, Journal of the Neurological Sciences.

[10]  A. Eisen,et al.  Inclusion body myositis , 1978, Neurology.

[11]  P. Isaacson,et al.  Malignant lymphoma and autoimmune disease , 1993, Histopathology.

[12]  Paolo Confalonieri,et al.  Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features , 1997, Journal of Neurology.

[13]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis , 1984, Annals of neurology.

[14]  S. Dimauro,et al.  Inclusion body myositis and myopathies , 1995, Annals of neurology.